Get the Stockscreener App
2.47
2.76%
-0.07
Q 32 Bio Inc Stock (QTTB) Latest News
Q32 Bio to Participate in Upcoming March Investor Conferences - PR Newswire
Fierce Biotech Layoff Tracker 2025: Moderna lays off 50 employees; Spotlight winds down - Fierce Biotech
Savant Capital LLC Makes New $53,000 Investment in Q32 Bio Inc. (NASDAQ:QTTB) - Defense World
Layoff Tracker: Spotlight Goes Dark After Disappointing Preclinical Data for CRISPR Platform - BioSpace
QTTB stock touches 52-week low at $2.44 amid market challenges - Investing.com
Piper Sandler cuts Q32 Bio stock rating to neutral, slashes target - MSN
What is Leerink Partnrs’ Forecast for Q32 Bio Q1 Earnings? - Defense World
Petri Dish: a new AbbVie deal, layoffs, and CFO departures - The Business Journals
Bleakley Financial Group LLC Invests $149,000 in Q32 Bio Inc. (NASDAQ:QTTB) - Defense World
Q32 Bio refocuses on alopecia treatment, ends renal trial - MSN
BMO cuts Q32 Bio stock rating, slashes price target to $3 - MSN
BMO Capital Downgrades Q32 Bio (LSE:0T6G) - Nasdaq
Q32 Bio (NASDAQ:QTTB) Lowered to “Market Perform” Rating by BMO Capital Markets - Defense World
Finance Watch: Third Harmonic, Q32 Bio Cut Jobs To Focus On Lead Assets - News & Insights
Q32 Bio halts trials amid job cuts and pivots to alopecia treatment - MSN
Q32 cut to neutral by Piper on ADX-097 discontinuation - MSN
Q32 Bio refocuses on alopecia treatment, ends renal trial By Investing.com - Investing.com Australia
BMO cuts Q32 Bio stock rating, slashes price target to $3 By Investing.com - Investing.com South Africa
Piper Sandler cuts Q32 Bio stock rating to neutral, slashes target By Investing.com - Investing.com South Africa
Piper Sandler Downgrades Q32 Bio (LSE:0T6G) - Nasdaq
This Columbus McKinnon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga
Q32 Bio lays off staff, focuses on alopecia program - The Pharma Letter
Q32 Bio sticks with bempikibart but loses staff and phase 2 complement inhibitor - Fierce Biotech
Brokerages Set Q32 Bio Inc. (NASDAQ:QTTB) Price Target at $29.86 - Defense World
FY2025 EPS Estimates for Q32 Bio Cut by Leerink Partnrs - Defense World
Q32 Bio Inc Restructuring Plan Includes Reduction In Force, Which Co Expects To Substantially Complete By End Of Q2 Of 2025 - Marketscreener.com
Q32 Bio Inc To Discontinue Renal Basket Trial For Adx-097 To Conserve Resources - Marketscreener.com
Q32 Bio Restructures to Focus on Bempikibart Development - TipRanks
Q32 Bio Announces Strategic Restructuring to Focus on Advancement of Bempikibart in Patients with Alopecia Areata - PR Newswire
Q32 Bio's Strategic Pivot: Alopecia Drug Shows 55-Week Efficacy as Company Streamlines Focus - StockTitan
Q32 Bio to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference - The Eastern Progress Online
QTTB stock touches 52-week low at $2.95 amid market challenges - MSN
Barclays PLC Acquires 5,353 Shares of Q32 Bio Inc. (NASDAQ:QTTB) - Defense World
Q32 Bio Inc. (NASDAQ:QTTB) Receives $29.86 Consensus Target Price from Brokerages - Defense World
Q32 Bio Advances Clinical Trials for Growth Opportunities - TipRanks
Pre-market Movers: ONCO, EYEN, SGMO, VSTM... - RTTNews
Q32 Bio Inc (QTTB) Could Be Worth Considering For The Next Few Weeks - Stocks Register
Arq Inc (ARQ) Analyst Thoughts: How High Can It Go? - Stocks Register
Analysts Update Their Estimates For Brunswick Corp - Stocks Register
At $1.81 Price, XCHG Ltd ADR (XCH) Is Sitting And Waiting - Stocks Register
Analysts Update Their Estimates For EPR Properties - Stocks Register
Protagenic Therapeutics Inc’s (PTIX) -12.44% Retreat Justifies A Second Look - Stocks Register
LegalZoom.com Inc (LZ) Volatility Hits 3.83% – Here Is What You Should Do - Stocks Register
At $18.67 Price, Osisko Gold Royalties Ltd (OR) Is Sitting And Waiting - Stocks Register
First Foundation Inc (FFWM): A New Perspective - Stocks Register
0.53%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):